As the U.S. stock market experiences a rise amidst a significant week of earnings reports and economic data releases, investors are keenly observing potential opportunities across various sectors. Penny stocks, often associated with smaller or newer companies, continue to attract attention for their affordability and growth potential despite their somewhat outdated name. By focusing on those with strong financial foundations, these stocks can offer both stability and upside potential for investors looking to explore lesser-known opportunities in the market.
Name | Share Price | Market Cap | Financial Health Rating |
BAB (OTCPK:BABB) | $0.78982 | $5.74M | ★★★★★★ |
LexinFintech Holdings (NasdaqGS:LX) | $3.12 | $512.97M | ★★★★★★ |
RLX Technology (NYSE:RLX) | $1.61 | $2.05B | ★★★★★★ |
ARC Document Solutions (NYSE:ARC) | $3.43 | $148.35M | ★★★★★★ |
Permianville Royalty Trust (NYSE:PVL) | $1.59 | $52.47M | ★★★★★★ |
Golden Growers Cooperative (OTCPK:GGRO.U) | $4.50 | $69.71M | ★★★★★★ |
MIND C.T.I (NasdaqGM:MNDO) | $1.88 | $39.06M | ★★★★★★ |
Better Choice (NYSEAM:BTTR) | $1.68 | $2.78M | ★★★★★★ |
Zynerba Pharmaceuticals (NasdaqCM:ZYNE) | $1.30 | $65.6M | ★★★★★☆ |
CBAK Energy Technology (NasdaqCM:CBAT) | $1.10 | $98.93M | ★★★★★☆ |
Click here to see the full list of 760 stocks from our US Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Newegg Commerce, Inc. is an electronics-focused e-retailer operating in the United States, Canada, and internationally with a market cap of $246.14 million.
Operations: The company's revenue is primarily generated from its online retail segment, which accounts for $1.39 billion.
Market Cap: $246.14M
Newegg Commerce, Inc. operates with a market cap of US$246.14 million, primarily generating revenue from its online retail segment, which stands at US$1.39 billion annually. Despite being unprofitable with a negative return on equity of -47.64%, the company maintains more cash than total debt and has sufficient cash runway for over three years if current positive free cash flow levels are sustained. Short-term assets exceed both short- and long-term liabilities, indicating financial stability in covering obligations. However, shareholders faced dilution last year as shares outstanding increased by 2.3%. Recent earnings show declining sales and reduced net losses compared to the previous year.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to developing and commercializing cancer care products globally, with a market cap of approximately $144.69 million.
Operations: The company generates $219.14 million in revenue from its segment focused on the development and commercialization of innovative cancer care products.
Market Cap: $144.69M
Puma Biotechnology, Inc., with a market cap of US$144.69 million, focuses on innovative cancer care products, generating US$219.14 million in revenue. The company has become profitable over the past five years but recently reported a net loss of US$4.53 million for Q2 2024, compared to a net income of US$2.1 million the previous year. Despite this setback, Puma's short-term assets exceed its liabilities and debt is well covered by cash flow; however, interest coverage remains weak at 2x EBIT. Shareholders experienced dilution as shares outstanding grew by 3.2%. Recent insider selling may raise concerns among investors.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Five Point Holdings, LLC, through its subsidiary Five Point Operating Company, LP, focuses on owning and developing mixed-use and planned communities in Orange County, Los Angeles County, and San Francisco County with a market cap of approximately $603.38 million.
Operations: The company's revenue segments include Valencia ($103.08 million), Commercial ($9.62 million), Great Park ($568.62 million), and San Francisco ($0.67 million).
Market Cap: $603.38M
Five Point Holdings, with a market cap of US$603.38 million, focuses on developing communities in key Californian counties. Recent earnings revealed revenue of US$17.01 million for Q3 2024, down from US$65.92 million the previous year, while net income decreased to US$4.76 million from US$6.6 million. The company's debt-to-equity ratio improved over five years but remains inadequately covered by cash flow at 3.7%. Despite lower profit margins and slower recent earnings growth compared to its historical average, Five Point's short-term assets significantly exceed both short and long-term liabilities, indicating strong liquidity positions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqCM:NEGG NasdaqGS:PBYI and NYSE:FPH.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。